UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 269

Sortiert nach

Development of broadly neutralizing antibodies in HIV-1 infected elite neutralizers

Retrovirology, 2018-09, Vol.15 (1), p.61-61, Article 61

2018

Link zum Volltext

Verfügbarkeit prüfen

IgG3 enhances neutralization potency and Fc effector function of an HIV V2-specific broadly neutralizing antibody

PLoS pathogens, 2019-12, Vol.15 (12), p.e1008064-e1008064

2019

Link zum Volltext

Verfügbarkeit prüfen

Viral escape from HIV-1 neutralizing antibodies drives increased plasma neutralization breadth through sequential recognition of multiple epitopes and immunotypes

PLoS pathogens, 2013-10, Vol.9 (10), p.e1003738-e1003738

2013

Link zum Volltext

Verfügbarkeit prüfen

The Neutralizing Antibody Response to the HIV-1 Env Protein

Current HIV research, 2018, Vol.16 (1), p.21

Moore, Penny L

2018

Link zum Volltext

Verfügbarkeit prüfen

The Neutralization Breadth of HIV-1 Develops Incrementally over Four Years and Is Associated with CD4+ T Cell Decline and High Viral Load during Acute Infection

Journal of Virology, 2011-05, Vol.85 (10), p.4828-4840

2011

Link zum Volltext

Verfügbarkeit prüfen

Leveraging on past investment in understanding the immunology of COVID-19 - the South African experience

South African Journal of Science, 2022-05, Vol.118 (5-6), p.15-19

2022

Link zum Volltext

Verfügbarkeit prüfen

Dependence on a variable residue limits the breadth of an HIV MPER neutralizing antibody, despite convergent evolution with broadly neutralizing antibodies

PLoS pathogens, 2022-09, Vol.18 (9), p.e1010450-e1010450

2022

Link zum Volltext

Verfügbarkeit prüfen

HIV-specific Fc effector function early in infection predicts the development of broadly neutralizing antibodies

PLoS pathogens, 2018-04, Vol.14 (4), p.e1006987-e1006987

2018

Link zum Volltext

Verfügbarkeit prüfen

Evolution of an HIV glycan-dependent broadly neutralizing antibody epitope through immune escape

Nature medicine, 2012-11, Vol.18 (11), p.1688-1692

2012

Link zum Volltext

Verfügbarkeit prüfen

Novavax NVX-COV2373 triggers neutralization of Omicron sub-lineages

Scientific reports, 2023-01, Vol.13 (1), p.1222-1222, Article 1222

2023

Link zum Volltext

Verfügbarkeit prüfen

Common helical V1V2 conformations of HIV-1 Envelope expose the α4β7 binding site on intact virions

Nature communications, 2018-10, Vol.9 (1), p.4489-14, Article 4489

2018

Link zum Volltext

Verfügbarkeit prüfen

HIV Broadly Neutralizing Antibodies Expressed as IgG3 Preserve Neutralization Potency and Show Improved Fc Effector Function

Frontiers in immunology, 2021-09, Vol.12, p.733958-733958

2021

Link zum Volltext

Verfügbarkeit prüfen

ADCC-mediating non-neutralizing antibodies can exert immune pressure in early HIV-1 infection

PLoS pathogens, 2021-11, Vol.17 (11), p.e1010046-e1010046

2021

Link zum Volltext

Verfügbarkeit prüfen

The adjuvant AlhydroGel elicits higher antibody titres than AddaVax when combined with HIV-1 subtype C gp140 from CAP256

PloS one, 2018-12, Vol.13 (12), p.e0208310-e0208310

2018

Link zum Volltext

Verfügbarkeit prüfen

Triggering rare HIV antibodies by vaccination

Science (American Association for the Advancement of Science), 2022-12, Vol.378 (6623), p.949-950

Moore, Penny L.

2022

Link zum Volltext

Verfügbarkeit prüfen

HIV-1 Glycan Density Drives the Persistence of the Mannose Patch within an Infected Individual

Journal of virology, 2016-12, Vol.90 (24), p.11132-11144

2016

Link zum Volltext

Verfügbarkeit prüfen

SARS-CoV-2 exposure in Malawian blood donors: an analysis of seroprevalence and variant dynamics between January 2020 and July 2021

BMC medicine, 2021-11, Vol.19 (1), p.303-303, Article 303

2021

Link zum Volltext

Verfügbarkeit prüfen

Polyclonal B Cell Responses to Conserved Neutralization Epitopes in a Subset of HIV-1-Infected Individuals

Journal of Virology, 2011-11, Vol.85 (21), p.11502-11519

2011

Link zum Volltext

Verfügbarkeit prüfen

Development of broadly neutralizing antibodies from autologous neutralizing antibody responses in HIV infection

Current opinion in HIV & AIDS, 2014-05, Vol.9 (3), p.210

2014

Link zum Volltext

Verfügbarkeit prüfen

Building a Resilient Scientific Network for COVID-19 and Beyond

mBio, 2022-10, Vol.13 (5), p.e0222322-e0222322

2022

Link zum Volltext

Verfügbarkeit prüfen

Limited neutralizing antibody specificities drive neutralization escape in early HIV-1 subtype C infection

PLoS pathogens, 2009-09, Vol.5 (9), p.e1000598-e1000598

2009

Link zum Volltext

Verfügbarkeit prüfen

Enhanced neutralization potency of an identical HIV neutralizing antibody expressed as different isotypes is achieved through genetically distinct mechanisms

Scientific reports, 2022-10, Vol.12 (1), p.16473-16473, Article 16473

2022

Link zum Volltext

Verfügbarkeit prüfen

Structure of Super-Potent Antibody CAP256-VRC26.25 in Complex with HIV-1 Envelope Reveals a Combined Mode of Trimer-Apex Recognition

Cell reports (Cambridge), 2020-04, Vol.31 (1), p.107488-107488, Article 107488

2020

Link zum Volltext

Verfügbarkeit prüfen

Cooperation between Strain-Specific and Broadly Neutralizing Responses Limited Viral Escape and Prolonged the Exposure of the Broadly Neutralizing Epitope

Journal of virology, 2017-09, Vol.91 (18)

2017

Link zum Volltext

Verfügbarkeit prüfen

Needle-Free Devices and CpG-Adjuvanted DNA Improve Anti-HIV Antibody Responses of Both DNA and Modified Vaccinia Ankara-Vectored Candidate Vaccines

Vaccines (Basel), 2023-02, Vol.11 (2), p.376

2023

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 269

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(247)
Mit Volltextzugriff
(240)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(180)
Life Sciences & Biomedicine
(159)
Humans
(145)
Virology
(72)
Female
(63)
Hiv
(60)
Immunology
(60)
Hiv-1 - Immunology
(57)
Hiv Infections - Immunology
(52)
Vaccines
(52)
Antibodies
(51)
Human Immunodeficiency Virus
(51)
Microbiology
(44)
Antibodies, Neutralizing - Immunology
(43)
Hiv Antibodies - Immunology
(42)
Infections
(37)
Male
(36)
Adult
(34)
Hiv-1 - Genetics
(33)
Infectious Diseases
(32)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Development of broadly neutralizing antibodies in HIV-1 infected elite neutralizers

IgG3 enhances neutralization potency and Fc effector function of an HIV V2-specific broadly neutralizing antibody

Viral escape from HIV-1 neutralizing antibodies drives increased plasma neutralization breadth through sequential recognition of multiple epitopes and immunotypes

The Neutralizing Antibody Response to the HIV-1 Env Protein

The Neutralization Breadth of HIV-1 Develops Incrementally over Four Years and Is Associated with CD4+ T Cell Decline and High Viral Load during Acute Infection

Leveraging on past investment in understanding the immunology of COVID-19 - the South African experience

Dependence on a variable residue limits the breadth of an HIV MPER neutralizing antibody, despite convergent evolution with broadly neutralizing antibodies

HIV-specific Fc effector function early in infection predicts the development of broadly neutralizing antibodies

Evolution of an HIV glycan-dependent broadly neutralizing antibody epitope through immune escape

Novavax NVX-COV2373 triggers neutralization of Omicron sub-lineages

Common helical V1V2 conformations of HIV-1 Envelope expose the α4β7 binding site on intact virions

HIV Broadly Neutralizing Antibodies Expressed as IgG3 Preserve Neutralization Potency and Show Improved Fc Effector Function

ADCC-mediating non-neutralizing antibodies can exert immune pressure in early HIV-1 infection

The adjuvant AlhydroGel elicits higher antibody titres than AddaVax when combined with HIV-1 subtype C gp140 from CAP256

Triggering rare HIV antibodies by vaccination

HIV-1 Glycan Density Drives the Persistence of the Mannose Patch within an Infected Individual

SARS-CoV-2 exposure in Malawian blood donors: an analysis of seroprevalence and variant dynamics between January 2020 and July 2021

Polyclonal B Cell Responses to Conserved Neutralization Epitopes in a Subset of HIV-1-Infected Individuals

Development of broadly neutralizing antibodies from autologous neutralizing antibody responses in HIV infection

Building a Resilient Scientific Network for COVID-19 and Beyond

Limited neutralizing antibody specificities drive neutralization escape in early HIV-1 subtype C infection

Enhanced neutralization potency of an identical HIV neutralizing antibody expressed as different isotypes is achieved through genetically distinct mechanisms

Structure of Super-Potent Antibody CAP256-VRC26.25 in Complex with HIV-1 Envelope Reveals a Combined Mode of Trimer-Apex Recognition

Cooperation between Strain-Specific and Broadly Neutralizing Responses Limited Viral Escape and Prolonged the Exposure of the Broadly Neutralizing Epitope

Needle-Free Devices and CpG-Adjuvanted DNA Improve Anti-HIV Antibody Responses of Both DNA and Modified Vaccinia Ankara-Vectored Candidate Vaccines

Suchergebnisse filtern